INMUNE BIO INC (INMB) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:INMB • US45782T1051

1.55 USD
-0.03 (-1.9%)
At close: Feb 3, 2026
1.55 USD
0 (0%)
After Hours: 2/3/2026, 8:24:56 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to INMB. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 5.36. This target is 245.48% above the current price.
  • INMB was analyzed by 10 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about INMB.
  • In the previous month the buy percentage consensus was at a similar level.
  • INMB was analyzed by 10 analysts. More opinions would make the average more meaningful.
INMB Historical Analyst RatingsINMB Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -81 -73 -65 -57 -49 -41 -33 -25 -17 -9 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 1.552.025.615.368.40 - 30.32% 261.94% 245.48% 441.94%
INMB Current Analyst RatingINMB Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5
Up and Down Grades
Date Firm Action Rating
2025-07-02 Maxim Group Maintains Buy -> Buy
2025-07-01 ScotiaBank Downgrade Sector Outperform -> Sector Underperform
2025-07-01 BTIG Downgrade Buy -> Neutral
2025-02-13 Maxim Group Maintains Buy -> Buy
2025-02-11 ScotiaBank Maintains Sector Outperform -> Sector Outperform
2024-10-21 Alliance Global Partners Initiate Buy
2024-09-27 Raymond James Initiate Outperform
2024-08-22 ScotiaBank Initiate Sector Outperform
2023-06-01 Baird Initiate Outperform
2022-05-24 BTIG Maintains Buy
2022-05-24 B. Riley Securities Downgrade Buy -> Neutral
2022-01-24 B. Riley Securities Maintains Buy
2021-04-21 B. Riley FBR Initiate Buy

INMUNE BIO INC / INMB FAQ

What is the average price target for INMUNE BIO INC (INMB) stock?

10 analysts have analysed INMB and the average price target is 5.36 USD. This implies a price increase of 245.48% is expected in the next year compared to the current price of 1.55.


What is the consensus rating for INMB stock?

The consensus rating for INMUNE BIO INC (INMB) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.